Eisai units merge, named Eisai India

April 18, 2015 11:20 pm | Updated 11:20 pm IST - VISAKHAPATNAM:

Eisai Pharmatechnology and Manufacturing Pvt. Ltd. and Eisai Pharmaceuticals India Pvt. Ltd, located at Visakhapatnam and Mumbai, respectively, have been amalgamated. Both are subsidiaries of Eisai Co. Ltd. (headquarters at Tokyo). The new entity is known as Eisai Pharmaceuticals India Pvt. Ltd.

Eisai Co. is a global R&D based pharmaceutical company.

As part of its commitment to the global initiative, Eisai has agreed to supply 2.2 billion diethylcarbamazinecitrate (DEC) 100 mg tablets free of charge to the World Health Organisation under the Mass Drug Administration (MDA) programme for eliminating lymphatic filariasis, said Managing Director of the new entity, Sanjit Singh Lamba.

Eisai has commenced the supply of DEC tablets from its Visakhapatnam plant.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.